Enzolytics Inc (ENZC)

[foxi]

I don't think we're in disagreement on most of this, the PRs read like bad legalese (specific words to sound like one thing but mean another) when paired with the lack of performance.

ENZC is at ECRM this week doing exactly what they did in ECRM in March, and they and their star marketing firm couldn't sell a single bottle of IPF due to overwhelming demand.

ITV-1 will be "introduced" in Africa in early April, except it still isn't. And it maybe isn't even funded.

EMA Phase 1 is Africa as far as I know. "First in human" trials are part of phase 1. Voluntary human trials at two unnamed African hospitals is how it will be "introduced".

The audit and regularly occurring yield signs are red flags.



We're not omniscient and it's possible the management trying to spin their weaknesses is the problem here, not the tech. ENZC will need A-games from both if they want to succeed.

Reputation is very important. Doing things in order is important. Communicating about it is important. Realistically, how fast do you think a five person biotech with this many moving parts can move? Is it realistic to not expect missteps and setbacks along the way?

But I heartily agree they have to stop acting like a pinkie if they want to be taken seriously.



.